Request translation

Please provide the email address where you would like to receive the Spanish translation of the news article:

Long-Term Outcomes and Quality of Life in High-Risk Neuroblastoma Patients Treated with Multimodal Therapy Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study
Emailaa
Fields marked with (*) are required.The information provided will be strictly confidential.

January 5, 2025

Long-Term Outcomes and Quality of Life in High-Risk Neuroblastoma Patients Treated with Multimodal Therapy Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study

by Tim Flaadt ,Jonás Rehm ,Thorsten Simón ,Bárbara Héroe ,Ruth L. Ladenstein ,Holger N. Lode ,Desiree Grabow ,Sandra Nolte ,Crazzolara romano ,Juan Greil ,Martín Ebinger ,Michael Abele ,Úrsula Holzer ,Michaela Döring ,Johannes H. Schulte ,Pedro Bader ,Paul-Gerhardt Schlegel ,Matías Eyrich ,Peter Lang ,Thomas Klingebiel yagregar Mostrar lista completa de autores

Cancers 2025 , 17 (1), 149

View full article

Department of Haematology and Oncology, University Children’s Hospital, Eberhard Karls University Tuebingen, 72076 Tuebingen, Germany